p63 (EP174) Rabbit Monoclonal Primary Antibody
Specialties: Breast/Gynecological Pathology Genitourinary (GU) Pathology Pulmonary Pathology
p63 is a transcription factor that regulates many cell activities, including cell proliferation, maintenance, differentiation, adhesion, and apoptosis.1 It has been found to be a sensitive and specific marker of myoepithelial and basal cell populations in prostate, breast, skin, and salivary gland. Additionally, p63 has also demonstrated immunohistochemical utility in identifying benign and malignant breast lesions.2 In prostatic carcinomas, it can also be used to recognize benign glands adjacent to malignant glands.3 p63 can also be used to differentiate adenocarcinoma of the lungs, where it is usually negative, from squamous cell carcinoma, which can be useful for advanced stages of the carcinoma where surgery is no longer an option.4
- Yang, A et al. "p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities." Molecular cell vol. 2,3 (1998): 305-16. doi:10.1016/s1097-2765(00)80275-0
- Stefanou, D et al. "p63 expression in benign and malignant breast lesions." Histology and histopathology vol. 19,2 (2004): 465-71. doi:10.14670/HH-19.465
- Jiang, Zhong et al. "Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens." American journal of clinical pathology vol. 123,2 (2005): 231-6. doi:10.1309/1g1nk9dbgfnb792l
- Camilo, Ricardo et al. "Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas." Human pathology vol. 37,5 (2006): 542-6. doi:10.1016/j.humpath.2005.12.019
Specifications
- Reactivity: paraffin
- Control: Lung squamous cell carcinoma (Nuclear); Prostate (Nuclear)
- Dilution Range: 1:100-1:200 *
Package Inserts
IFU
- IVD Rev. 0.0 (CMC48231000)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 25.0 mL predilute ready-to-use | 482R-10 |
| 0.1 mL concentrate | 482R-14 |
| 0.5 mL concentrate | 482R-15 |
| 1.0 mL concentrate | 482R-16 |
| 1.0 mL predilute ready-to-use | 482R-17 |
| 7.0 mL predilute ready-to-use | 482R-18 |
For research use only (RUO) in Canada
| 25.0 mL predilute ready-to-use (RUO) | 482R-10-RUO |
| 0.1 mL concentrate (RUO) | 482R-14-RUO |
| 1.0 mL concentrate (RUO) | 482R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 482R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 482R-18-RUO |
For in vitro diagnostic (IVD) use in Europe
| 25.0 mL predilute ready-to-use | 482R-10 |
| 0.1 mL concentrate | 482R-14 |
| 0.5 mL concentrate | 482R-15 |
| 1.0 mL concentrate | 482R-16 |
| 1.0 mL predilute ready-to-use | 482R-17 |
| 7.0 mL predilute ready-to-use | 482R-18 |
For research use only (RUO) in Japan
| 25.0 mL predilute ready-to-use (RUO) | 482R-10-RUO |
| 0.1 mL concentrate (RUO) | 482R-14-RUO |
| 1.0 mL concentrate (RUO) | 482R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 482R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 482R-18-RUO |
To request information on this product in additional countries, please click the button below.
